Omnicell (OMCL) Free Cash Flow (2010 - 2026)
Omnicell's (OMCL) quarterly Free Cash Flow came in at $59.4 million in Q2 2026, up 91.69% year-over-year from $31.0 million in Q2 2025, and up 41.15% quarter-over-quarter from $42.1 million in Q1 2026.
Analysis
Omnicell (OMCL) Free Cash Flow (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Free Cash Flow for 17 consecutive years, with $59.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Free Cash Flow rose 91.69% year-over-year to $59.4 million in Q2 2026; TTM through Jun 2026 was $142.6 million, a 33.47% increase from a year earlier, with the FY2025 full-year figure at $86.9 million, down 42.56% from the prior year.
- Free Cash Flow was $59.4 million for Q2 2026 at Omnicell, up from $42.1 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $68.5 million in Q4 2022 and troughed at -$27.5 million in Q1 2022.
- A 5-year average of $28.3 million and a median of $30.2 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow slumped 152.53% in 2022 and soared 1459.38% in 2024, its largest moves.
- Over 5 years, Free Cash Flow stood at $68.5 million in 2022, then slumped by 57.15% to $29.3 million in 2023, then jumped by 60.95% to $47.2 million in 2024, then tumbled by 52.05% to $22.6 million in 2025, then surged by 162.19% to $59.4 million in 2026.
- The last three Free Cash Flow figures came in at $59.4 million (Q2 2026), $42.1 million (Q1 2026), and $22.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 948.40 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.29 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 1.06 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 1.28 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 585.00 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 606.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 184.50 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 403.50 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 59.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.37 Mn |
| Mar 31, 2026 | 42.07 Mn |
| Dec 31, 2025 | 22.65 Mn |
| Sep 30, 2025 | 18.51 Mn |
| Jun 30, 2025 | 30.97 Mn |
| Mar 31, 2025 | 14.75 Mn |
| Dec 31, 2024 | 47.23 Mn |
| Sep 30, 2024 | 13.89 Mn |
| Jun 30, 2024 | 49.15 Mn |
| Mar 31, 2024 | 41.00 Mn |
| Dec 31, 2023 | 29.34 Mn |
| Sep 30, 2023 | 46.38 Mn |
| Jun 30, 2023 | 61.27 Mn |
| Mar 31, 2023 | 2.63 Mn |
| Dec 31, 2022 | 68.48 Mn |
| Sep 30, 2022 | 8.41 Mn |
| Jun 30, 2022 | -19.16 Mn |
| Mar 31, 2022 | -27.49 Mn |
| Dec 31, 2021 | 48.56 Mn |
| Sep 30, 2021 | 36.16 Mn |